Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaopiruanfang is a Traditional Chinese Medicine (TCM) herbal preparation developed for the treatment of hyperplasia of mammary glands. It is designed to regulate qi, activate blood circulation, resolve stagnation, soften hardened tissues, and clear heat, thereby promoting the smooth flow and health of mammary glands. The preparation is composed of multiple herbal ingredients, including vinegar-processed Bupleurum root, vinegar-processed Corydalis rhizome, vinegar-processed Citrus reticulata pericarp, vinegar-processed Cyperus rotundus rhizome, vinegar-processed Sparganium rhizome, vinegar-processed Curcuma zedoaria rhizome, Curcuma longa tuber, Sargassum, Laminaria, Fritillaria thunbergii bulb, Musk, Pangolin scales, Hawthorn fruit, and Vaccaria seed. It is administered orally in capsule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaopiruanfang.